BeOne Medicines Ltd. (ONC): Total Liabilities
$3.83B
As of 2025-12-31
$4.00B
As of 2026-06-30
+24.2%
3-year compound annual growth
+17.2%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.83B | +47.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $2.59B | +14.1% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $2.27B | +13.6% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $2.00B | -16.9% | 2024-02-26, Balance as of period end |
| 2021-12-31 | $2.40B | +38.8% | 2023-02-27, Balance as of period end |
| 2020-12-31 | $1.73B | +173.1% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $633.93M | +27.8% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $496.04M | +36.9% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $362.25M | +584.7% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $52.91M | +24.6% | 2018-02-28, Balance as of period end |
| 2015-12-31 | $42.45M | n/a | 2017-03-22, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $3.83B | +47.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.81B | +4.5% |
| Organon & Co. (OGN) | 2025-12-31 | $12.12B | -4.1% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $5.60B | +5.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $4.18B | +0.1% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $1.51B | +13.2% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $783.80M | -14.8% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $12.14B | +28.2% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $25.99B | -3.2% |
Compare ONC, ELAN, OGN, PRGO side by side · Screen every company in Pharmaceutical Preparations ↗